138 related articles for article (PubMed ID: 33289184)
1. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1.
Zhang XL; Zhang G; Bai ZH
Cell Biol Int; 2021 Mar; 45(3):642-653. PubMed ID: 33289184
[TBL] [Abstract][Full Text] [Related]
2. miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy.
Yang XX; Zhao ZY
Can J Physiol Pharmacol; 2022 Feb; 100(2):167-175. PubMed ID: 35025607
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
5. Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice.
Wang W; Zhang S; Xu L; Feng Y; Wu X; Zhang M; Yu Z; Zhou X
Diabetologia; 2021 Mar; 64(3):681-692. PubMed ID: 33398455
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
Sun H; Wang C; Zhou Y; Cheng X
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
[TBL] [Abstract][Full Text] [Related]
8. Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model.
Shen L; Li L; Li M; Wang W; Yin W; Liu W; Hu Y
Int J Mol Med; 2018 Dec; 42(6):3017-3026. PubMed ID: 30221681
[TBL] [Abstract][Full Text] [Related]
9. HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation.
Ouyang C; Huang L; Ye X; Ren M; Han Z
Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):660-670. PubMed ID: 35760306
[TBL] [Abstract][Full Text] [Related]
10. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.
Zhang Y; Wang JH; Zhang YY; Wang YZ; Wang J; Zhao Y; Jin XX; Xue GL; Li PH; Sun YL; Huang QH; Song XT; Zhang ZR; Gao X; Yang BF; Du ZM; Pan ZW
Sci Rep; 2016 Mar; 6():23010. PubMed ID: 26972749
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
Liu B; Wei Y; He J; Feng B; Chen Y; Guo R; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
Stem Cell Res Ther; 2024 Apr; 15(1):120. PubMed ID: 38659015
[TBL] [Abstract][Full Text] [Related]
12. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
13. NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn.
Liu Y; Zhu Y; Liu S; Liu J; Li X
Inflamm Res; 2021 Dec; 70(10-12):1113-1127. PubMed ID: 34591118
[TBL] [Abstract][Full Text] [Related]
14. GAS5 regulates diabetic cardiomyopathy via miR‑221‑3p/p27 axis‑associated autophagy.
Chen D; Zhang M
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313941
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA-145a-5p/Cfl2 Axis.
Wang K; Lin Y; Shen H; Yu S; Xu J
J Cardiovasc Pharmacol; 2023 Mar; 81(3):192-202. PubMed ID: 36450139
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Pin1 alleviates myocardial fibrosis and dysfunction in STZ-induced diabetic mice.
Liu X; Liang E; Song X; Du Z; Zhang Y; Zhao Y
Biochem Biophys Res Commun; 2016 Oct; 479(1):109-15. PubMed ID: 27634219
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction.
Zhang L; Yin H; Jiao L; Liu T; Gao Y; Shao Y; Zhang Y; Shan H; Zhang Y; Yang B
Cell Physiol Biochem; 2018; 45(4):1641-1653. PubMed ID: 29486470
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
19. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
